Zhitong HK Morning Briefing | State Council Issues Guidelines on Combating Tobacco-Related Illegal Activities; Overnight US Stocks Rise Across the Board

Stock News
9 hours ago

**Top Headline** Two studies published on *Nature*'s website confirm the efficacy and safety of a new diabetes drug developed jointly by Chinese and US pharmaceutical companies. The research, conducted on Chinese patients with type 2 diabetes, demonstrated that Mazdutide outperformed placebo or dulaglutide in blood sugar control and weight loss while improving cardiovascular, liver, and kidney-related indicators. Mazdutide is a dual glucagon/GLP-1 receptor agonist co-developed by Innovent Biologics (01801) and Eli Lilly.

Dr. Qian Lei, Chief R&D Officer at Innovent, stated that the findings provide high-quality evidence for treating overweight, obesity, and diabetes, showcasing China's research capabilities in the field. Obesity exacerbates insulin resistance, a major factor in type 2 diabetes progression and complications affecting blood vessels, eyes, kidneys, and feet.

**Market Overview** Overnight, US stocks closed higher: - Dow Jones rose 0.14% to 47,951.85. - S&P 500 gained 0.79% to 6,774.76. - Nasdaq surged 1.38% to 23,006.36.

Tech stocks led gains, with Tesla up over 3%, and Amazon and Meta rising over 2%. Memory and semiconductor stocks also advanced, with Micron up 10% and SanDisk over 6%. Most US-listed Chinese stocks rose, including Zhihu (+3%) and XPeng (+2%). The Hang Seng Index ADR climbed 0.18% to 25,544.89.

**Key Developments** 1. **State Council Issues Guidelines on Combating Tobacco-Related Illegal Activities** The State Council released measures targeting counterfeit production, smuggling, and sales to safeguard national interests and consumer rights. The policy emphasizes cross-border enforcement cooperation and domestic crackdowns, potentially benefiting CTIHK (06055).

2. **BHP CEO: Copper Supply Crunch to Sustain High Prices for Years** CEO Mike Henry highlighted copper's critical role in decarbonization and digitalization, forecasting a 70% demand surge by 2050 amid constrained supply due to fewer discoveries and challenging mining conditions.

3. **Xinte Energy (01799) Subsidiary Transfers 79.92% Partnership Stake** Inner Mongolia Energy, a subsidiary, transferred its stake to an asset manager under a support plan, with no additional payment beyond capital contributions.

4. **Meituan (03690) Open-Sources SOTA Virtual Avatar Video Model** Meituan’s LongCat team launched LongCat-Video-Avatar, enhancing realism, stability, and identity consistency in AI-generated videos.

5. **IPO Watch: Wisdom Mining (02546) Surges 126.16% in Gray Market** The Tibet-focused zinc, lead, and copper miner’s shares soared ahead of its HKEX debut, with one lot yielding HK$5,690.

6. **Evergrande Auto (00708) Subsidiary Ownership Transferred to Guangzhou Juli** Following a court-approved restructuring, the subsidiary’s equity was canceled and re-registered under Guangzhou Juli without cash consideration. Trading remains suspended.

**Stock Spotlight: Wasion Holdings (03393)** Its Brazilian subsidiary, Wasion da Amazônia, secured an RMB80+ million contract with CPFL, Brazil’s second-largest power utility. The company projects AI data center revenue to double annually, reaching RMB4 billion by 2027. Citigroup raised its target price to HK$21, citing strong order momentum and potential inclusion in Stock Connect.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10